Heterogeneity and mitochondrial vulnerability configurate the divergent immunoreactivity of human induced microglia-like cells.

[1]  Y. Sakai,et al.  Mitochondrial Calcium-Triggered Oxidative Stress and Developmental Defects in Dopaminergic Neurons Differentiated from Deciduous Teeth-Derived Dental Pulp Stem Cells with MFF Insufficiency , 2022, Antioxidants.

[2]  Na Liu,et al.  Mitochondrial-derived damage-associated molecular patterns amplify neuroinflammation in neurodegenerative diseases , 2022, Acta Pharmacologica Sinica.

[3]  J. Plemel,et al.  Central nervous system macrophages in progressive multiple sclerosis: relationship to neurodegeneration and therapeutics , 2022, Journal of neuroinflammation.

[4]  S. Elledge,et al.  Longitudinal analysis reveals high prevalence of Epstein-Barr virus associated with multiple sclerosis , 2022, Science.

[5]  D. Reich,et al.  Multiple sclerosis in 2021: progress against progression , 2022, The Lancet Neurology.

[6]  Oliver M. Crook,et al.  Spatiotemporal proteomic profiling of the pro-inflammatory response to lipopolysaccharide in the THP-1 human leukaemia cell line , 2021, Nature Communications.

[7]  Y. Sakai,et al.  Progressive B cell depletion in human MALT1 deficiency , 2021, Clinical and experimental immunology.

[8]  D. Kang,et al.  Mitochondrial Reactive Oxygen Species Are Essential for the Development of Psoriatic Inflammation , 2021, Frontiers in Immunology.

[9]  Satoshi O. Suzuki,et al.  CD206 Expression in Induced Microglia-Like Cells From Peripheral Blood as a Surrogate Biomarker for the Specific Immune Microenvironment of Neurosurgical Diseases Including Glioma , 2021, Frontiers in Immunology.

[10]  R. Koyama,et al.  Microglia regulate synaptic development and plasticity , 2021, Developmental neurobiology.

[11]  A. Regev,et al.  Single cell RNA sequencing of human microglia uncovers a subset associated with Alzheimer’s disease , 2020, Nature Communications.

[12]  Wugang Hou,et al.  Microglia: A Potential Therapeutic Target for Sepsis-Associated Encephalopathy and Sepsis-Associated Chronic Pain , 2020, Frontiers in Pharmacology.

[13]  A. Gaultier,et al.  Modulation of PKM activity affects the differentiation of TH17 cells , 2020, Science Signaling.

[14]  Takahiro A. Kato,et al.  GNAO1 organizes the cytoskeletal remodeling and firing of developing neurons , 2020, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[15]  J. Takanashi,et al.  Guidelines for the diagnosis and treatment of acute encephalopathy in childhood , 2020, Brain and Development.

[16]  F. Ginhoux,et al.  Early Fate Defines Microglia and Non-parenchymal Brain Macrophage Development , 2020, Cell.

[17]  J. Dunn,et al.  Control of brain tumor growth by reactivating myeloid cells with niacin , 2020, Science Translational Medicine.

[18]  S. Zheng,et al.  Nuclear Factor κB (NF-κB)–Mediated Inflammation in Multiple Sclerosis , 2020, Frontiers in Immunology.

[19]  N. Sicotte,et al.  Microglia in Multiple Sclerosis: Friend or Foe? , 2020, Frontiers in Immunology.

[20]  Ashish,et al.  Pyruvate Kinase M2 and Cancer: The Role of PKM2 in Promoting Tumorigenesis , 2020, Frontiers in Oncology.

[21]  A. Vanderver,et al.  Associations of paediatric demyelinating and encephalitic syndromes with myelin oligodendrocyte glycoprotein antibodies: a multicentre observational study , 2020, The Lancet Neurology.

[22]  R. Sankowski,et al.  Microglia Heterogeneity in the Single-Cell Era. , 2020, Cell reports.

[23]  J. A. Stratton,et al.  Microglia response following acute demyelination is heterogeneous and limits infiltrating macrophage dispersion , 2020, Science Advances.

[24]  K. Mills,et al.  Pharmacological Activation of Pyruvate Kinase M2 Inhibits CD4+ T Cell Pathogenicity and Suppresses Autoimmunity , 2019, Cell metabolism.

[25]  E. Shigetomi,et al.  Reactive astrocyte-driven epileptogenesis is induced by microglia initially activated following status epilepticus , 2019, bioRxiv.

[26]  D. Arnold,et al.  Serial Anti–Myelin Oligodendrocyte Glycoprotein Antibody Analyses and Outcomes in Children With Demyelinating Syndromes , 2019, JAMA neurology.

[27]  J. Schultze,et al.  Human Monocyte Subsets and Phenotypes in Major Chronic Inflammatory Diseases , 2019, Front. Immunol..

[28]  G. Cenini,et al.  Mitochondria as Potential Targets in Alzheimer Disease Therapy: An Update , 2019, Front. Pharmacol..

[29]  V. Yong,et al.  When encephalitogenic T cells collaborate with microglia in multiple sclerosis , 2019, Nature Reviews Neurology.

[30]  M. Tremblay,et al.  Microglial subtypes: diversity within the microglial community , 2019, The EMBO journal.

[31]  Sagar,et al.  Author Correction: Spatial and temporal heterogeneity of mouse and human microglia at single-cell resolution , 2019, Nature.

[32]  C. Culmsee,et al.  Mitochondria, Microglia, and the Immune System—How Are They Linked in Affective Disorders? , 2019, Front. Psychiatry.

[33]  Satoshi O. Suzuki,et al.  Subcortical axonal loss with glial reactions following partial status epilepticus with neuroradiological findings of reduced subcortical diffusion , 2018, Neurological Sciences.

[34]  R. Kahn,et al.  Microglia innately develop within cerebral organoids , 2018, Nature Communications.

[35]  A. Prescott,et al.  Basal Mitophagy Occurs Independently of PINK1 in Mouse Tissues of High Metabolic Demand , 2018, Cell metabolism.

[36]  B. Barres,et al.  Microglia and macrophages in brain homeostasis and disease , 2017, Nature Reviews Immunology.

[37]  Robin Patel,et al.  Human Gut-Derived Commensal Bacteria Suppress CNS Inflammatory and Demyelinating Disease. , 2017, Cell reports.

[38]  H. Yamaza,et al.  Mitochondria Regulate the Differentiation of Stem Cells from Human Exfoliated Deciduous Teeth. , 2017, Cell structure and function.

[39]  J. Grau,et al.  Pyruvate kinase M2 and the mitochondrial ATPase Inhibitory Factor 1 provide novel biomarkers of dermatomyositis: a metabolic link to oncogenesis , 2017, Journal of Translational Medicine.

[40]  J. Takanashi,et al.  A nationwide survey of pediatric acquired demyelinating syndromes in Japan , 2016, Neurology.

[41]  R. Ransohoff.  A polarizing question: do M1 and M2 microglia exist? , 2016, Nature Neuroscience.

[42]  J. Takanashi,et al.  Activated microglia in acute encephalopathy with biphasic seizures and late reduced diffusion , 2016, Journal of the Neurological Sciences.

[43]  T. Assimes,et al.  The glycolytic enzyme PKM2 bridges metabolic and inflammatory dysfunction in coronary artery disease , 2016, The Journal of experimental medicine.

[44]  Tom Michoel,et al.  Microglial brain region-dependent diversity and selective regional sensitivities to ageing , 2015, Nature Neuroscience.

[45]  T. Goldmann,et al.  Fine-tuning of type I IFN-signaling in microglia — implications for homeostasis, CNS autoimmunity and interferonopathies , 2015, Current Opinion in Neurobiology.

[46]  E. Pilozzi,et al.  Modulation of PKM alternative splicing by PTBP1 promotes gemcitabine resistance in pancreatic cancer cells , 2015, Oncogene.

[47]  Takahiro A. Kato,et al.  Introducing directly induced microglia-like (iMG) cells from fresh human monocytes: a novel translational research tool for psychiatric disorders , 2015, Front. Cell. Neurosci..

[48]  J. Glass,et al.  Human neural stem cell transplantation in ALS: initial results from a phase I trial , 2015, Journal of Translational Medicine.

[49]  Susan R. Quinn,et al.  Pyruvate kinase M2 regulates Hif-1α activity and IL-1β induction and is a critical determinant of the warburg effect in LPS-activated macrophages. , 2015, Cell metabolism.

[50]  Haichao Wang,et al.  PKM2 Regulates the Warburg Effect and Promotes HMGB1 Release in Sepsis , 2014, Nature Communications.

[51]  Takahiro A. Kato,et al.  Direct induction of ramified microglia-like cells from human monocytes: Dynamic microglial dysfunction in Nasu-Hakola disease , 2014, Scientific Reports.

[52]  U. Hanisch,et al.  Microglial diversity by responses and responders , 2014, Front. Cell. Neurosci..

[53]  H. Lassmann,et al.  Mitochondrial dysfunction contributes to neurodegeneration in multiple sclerosis. , 2014, Trends in molecular medicine.

[54]  K. Carvalho,et al.  Mitochondrial dysfunction in demyelinating diseases. , 2013, Seminars in pediatric neurology.

[55]  Ben A. Barres,et al.  Microglia Sculpt Postnatal Neural Circuits in an Activity and Complement-Dependent Manner , 2012, Neuron.

[56]  J. Takanashi,et al.  Epidemiology of acute encephalopathy in Japan, with emphasis on the association of viruses and syndromes , 2012, Brain and Development.

[57]  F. Granucci,et al.  CD14 Controls the LPS-Induced Endocytosis of Toll-like Receptor 4 , 2011, Cell.

[58]  M. Giustetto,et al.  Synaptic Pruning by Microglia Is Necessary for Normal Brain Development , 2011, Science.

[59]  S. Girardin,et al.  Mitochondria in innate immunity , 2011, EMBO reports.

[60]  Matthew K. Knabel,et al.  Pyruvate Kinase M2 Is a PHD3-Stimulated Coactivator for Hypoxia-Inducible Factor 1 , 2011, Cell.

[61]  F. Ginhoux,et al.  Fate Mapping Analysis Reveals That Adult Microglia Derive from Primitive Macrophages , 2010, Science.

[62]  S. Anker,et al.  The anti‐CD14 antibody IC14 suppresses ex vivo endotoxin stimulated tumor necrosis factor‐alpha in patients with chronic heart failure , 2006, European journal of heart failure.

[63]  S. Fujimoto,et al.  Diffusion MRI abnormalities after prolonged febrile seizures with encephalopathy , 2006, Neurology.

[64]  R. Tellier,et al.  Epstein-Barr virus in pediatric multiple sclerosis. , 2004, JAMA.

[65]  K. Ishii,et al.  The LPS receptor (CD14) links innate immunity with Alzheimer's disease , 2004, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[66]  A G Brooks,et al.  Crystal structure of the extracellular domain of a human Fc gamma RIII. , 2000, Immunity.